{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Adagio Medical Holdings, Inc"},"Symbol":{"label":"Symbol","value":"ADGM"},"Address":{"label":"Address","value":"51 ASTOR PLACE,10TH FLOOR, NEW YORK, New York, 10003, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Adagio Medical, Inc., is a medical device company located in Laguna Hills, California. Co-founded in 2011 by Dr. James Cox, the inventor of gold standard Cox-Maze procedure, and Olav Bergheim, a serial entrepreneur, Adagio Medical is developing innovative ablation technologies for the treatment of cardiac arrhythmias including atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagios unique portfolio is based on Ultra-Low Temperature Cryoablation (ULTC) and Pulsed-Field Cryoablation (PFCA) designed to produce durable, contiguous, transmural lesions anywhere in the heart."},"CompanyUrl":{"label":"Company Url","value":null},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Hakon Bergheim","title":"Chief Operating Officer"},{"name":"Olav B. Bergheim","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}